{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:56:47Z","timestamp":1793717807700,"version":"4.6.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00467-018-3933-3","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T16:58:57Z","timestamp":1522688337000},"page":"1395-1403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Extra-Renal manifestations of atypical hemolytic uremic syndrome in children"],"prefix":"10.1007","volume":"33","author":[{"given":"Kibriya","family":"Fidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"G\u00f6knar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"G\u00fclhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Melek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Y.","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Bask\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutlu","family":"Hayran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"G\u00fclleroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep B.","family":"\u00d6z\u00e7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Ozaltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Soylemezoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"issue":"6","key":"3933_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.semarthrit.2013.11.004","volume":"43","author":"MH Rosove","year":"2014","unstructured":"Rosove MH (2014) Thrombotic microangiopathies. Semin Arthritis Rheum 43(6):797\u2013805","journal-title":"Semin Arthritis Rheum"},{"key":"3933_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60","journal-title":"Orphanet J Rare Dis"},{"key":"3933_CR3","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676\u20131687","journal-title":"N Engl J Med"},{"issue":"10","key":"3933_CR4","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5(10):1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"3933_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Femeaux Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, N\u00fcrnberg G, Altm\u00fcller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, N\u00fcrnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45(5):531\u2013536","journal-title":"Nat Genet"},{"issue":"3","key":"3933_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1681\/ASN.2012090903","volume":"24","author":"F Ozaltin","year":"2013","unstructured":"Ozaltin F, Li B, Rauhauser A, An SW, Soylemezoglu O, Gonul II, Taskiran EZ, Ibsirlioglu T, Korkmaz E, Bilginer Y, Duzova A, Ozen S, Topaloglu R, Besbas N, Ashraf S, Du Y, Liang C, Chen P, Lu D, Vadnagara K, Arbuckle S, Lewis D, Wakeland B, Quigg RJ, Ransom RF, Wakeland EK, Topham MK, Bazan NG, Mohan C, Hildebrandt F, Bakkaloglu A, Huang CL, Attanasio M (2013) DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol 24(3):377\u2013384","journal-title":"J Am Soc Nephrol"},{"key":"3933_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013050453","volume":"25","author":"F Bu","year":"2014","unstructured":"Bu F, Maga T, Meyer NC (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25:55\u201364","journal-title":"J Am Soc Nephrol"},{"key":"3933_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fped.2014.00097","volume":"2","author":"J Hofer","year":"2014","unstructured":"Hofer J, Rosales A, Fischer C, Giner T (2014) Extra renal manifestations of complement mediated thrombotic microangiopathies. Front Pediatr 2:97","journal-title":"Front Pediatr"},{"key":"3933_CR9","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","volume":"29","author":"S Johnson","year":"2014","unstructured":"Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM (2014) An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol 29:1967\u20131978","journal-title":"Pediatr Nephrol"},{"key":"3933_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaim\u00e9 F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Desch\u00eanes G, Lebranchu Y, Zuber J, Loirat C (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554\u2013562","journal-title":"Clin J Am Soc Nephrol"},{"key":"3933_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12882-016-0420-6","volume":"18","author":"N Besbas","year":"2017","unstructured":"Besbas N, Gulhan B, Soylemezoglu O, Ozcakar ZB, Korkmaz E, Hayran M, Ozaltin F (2017) Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients. BMC Nephrol 18:6","journal-title":"BMC Nephrol"},{"key":"3933_CR12","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s00467-010-1606-y","volume":"25","author":"B Koehl","year":"2010","unstructured":"Koehl B, Boyer O, Biebuyck-Gouge N, Kossorotoff M, Fr\u00e9meaux-Bacchi V, Boddaert N, Niaudet P (2010) Neurological involvement in a child with atypical hemolytic uremic syndrome. Pediatr Nephrol 25:2539\u20132542","journal-title":"Pediatr Nephrol"},{"key":"3933_CR13","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","volume":"12","author":"J Caprioli","year":"2003","unstructured":"Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G, Noris M, International Registry of Recurrent and Familial HUS\/TTP (2003) Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 12:3385\u20133395","journal-title":"Hum Mol Genet"},{"key":"3933_CR14","first-page":"366","volume":"451","author":"MJ Seddon","year":"2013","unstructured":"Seddon MJ, Yu Y, Miller EC, Reynolds R, Tan PL, Gowrisankar S, Goldstein JI, Triebwasser M, Anderson HE, Zerbib J, Kavanagh D, Souied E, Katsanis N, Daly MJ, Atkinson JP, Raychaudhuri S (2013) Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet 451:366\u2013370","journal-title":"Nat Genet"},{"key":"3933_CR15","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1182\/blood-2013-03-492421","volume":"122","author":"S Feng","year":"2013","unstructured":"Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V (2013) Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood 122:1487\u20131493","journal-title":"Blood"},{"key":"3933_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 31:1445\u20131460","journal-title":"Hum Mutat"},{"issue":"3","key":"3933_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","volume":"89","author":"LA Greenbaum","year":"2016","unstructured":"Greenbaum LA, Fila M, Ardissino G, Al-Akash S, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar N, Vande Walle J, Massayo O, Bedrosian CL, Licht C (2016) Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int 89(3):701\u2013711","journal-title":"Kidney Int"},{"key":"3933_CR18","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00467-012-2276-8","volume":"27","author":"R Vilalta","year":"2012","unstructured":"Vilalta R, Lara E, Madrid A, Chocron S, Mu\u00f1oz M, Casquero A, Nieto J (2012) Long-term eculizumab improves clinical outcome and in atypical hemolytic uremic syndrome. Pediatr Nephrol 27:2323\u20132326","journal-title":"Pediatr Nephrol"},{"key":"3933_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00467-013-2416-9","volume":"28","author":"K Gulleroglu","year":"2013","unstructured":"Gulleroglu K, Fidan K, Han\u00e7er VS, Bayrakci U, Baskin E, Soylemezoglu O (2013) Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol 28:827\u2013830","journal-title":"Pediatr Nephrol"},{"key":"3933_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00467-013-2709-z","volume":"29","author":"H Hu","year":"2014","unstructured":"Hu H, Nagra A, Haq MR, Gilbert R (2014) Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurolocal involvement. Pediatr Nephrol 29:1103\u20131106","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3933_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0887-8994(94)00121-H","volume":"12","author":"ND Barnett","year":"1995","unstructured":"Barnett ND, Kaplan AM, Bernes SM, Cohen ML (1995) Hemolytic uremic syndrome with particular involvement of basal ganglia and favorable outcome. Pediatr Neurol 12(2):155\u2013158","journal-title":"Pediatr Neurol"},{"key":"3933_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00467-014-3003-4","volume":"30","author":"E Baskin","year":"2015","unstructured":"Baskin E, Gulleroglu K, Kantar A, Bayrakci U, Ozkaya O (2015) Success of eculizumab in the treatment of atypical hemolytic uremic syndrome. Pediatr Nephrol 30:783\u2013789","journal-title":"Pediatr Nephrol"},{"key":"3933_CR23","first-page":"5","volume":"3","author":"M Ohanian","year":"2011","unstructured":"Ohanian M, Cable C, Halka K (2011) Eculizumab safely reverses neurologic impairment and eliminated need for dialysis in severe atypical hemolytic uremic syndrome. Clin Pharmacol 3:5\u201312","journal-title":"Clin Pharmacol"},{"key":"3933_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Fr\u00e9meaux-Bacchi V, HUS International (2016) An international consensus approach to the management of atypical haemolytic uremic syndrome in children. Pediatr Nephrol 31:15\u201339","journal-title":"Pediatr Nephrol"},{"key":"3933_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","volume":"27","author":"LM Geerdink","year":"2012","unstructured":"Geerdink LM, Westra D, Wijk V, Dorresteijn EM, Lilien MR, Davin JC, K\u00f6mhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC (2012) Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 27:1283\u20131291","journal-title":"Pediatr Nephrol"},{"key":"3933_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nrneph.2013.280","volume":"10","author":"M Noris","year":"2014","unstructured":"Noris M, Remuzzi G (2014) Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol 10:174\u2013180","journal-title":"Nat Rev Nephrol"},{"key":"3933_CR27","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","volume":"25","author":"M Sallee","year":"2010","unstructured":"Sallee M, Daniel L, Piercecchi MD, Jaubert D, Fremeaux-Bacchi V, Berland Y, Burtey S (2010) Myocardial infarction is a complication of factor-H associated atypical HUS. Nephrol Dial Transplant 25:2028\u20132032","journal-title":"Nephrol Dial Transplant"},{"key":"3933_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5414\/CN106829","volume":"77","author":"A Losito","year":"2012","unstructured":"Losito A, Pittavini L, Covarelli C (2012) Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case report of a patient treated with endothelin receptor antagonist. Clin Nephrol 77:164\u2013170","journal-title":"Clin Nephrol"},{"issue":"1","key":"3933_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1542\/peds.2012-0903","volume":"131","author":"M Malina","year":"2013","unstructured":"Malina M, Gulati A, Bagga A, Majid MA, Simkova E, Schaefer FMalina M, Gulati A, Bagga A, Majid MA, Simkova E, Schaefer F (2013) Peripheral gangrene in children with atypical hemolytic uremic syndrome. Pediatrics 131(1):331\u2013335","journal-title":"Pediatrics"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3933-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3933-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3933-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T19:22:09Z","timestamp":1554146529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3933-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3933"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3933-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"21 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Hacettepe University Ethics Committee (FON10\/03-22) and written informed consent was obtained from the parents of each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}